SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Frances Burney Synthetic CCD

PatientFrances Burney
Date of birth1967-06-13
IdentifiersMRN HR-EN013-SYN; SSN (made up) 000-13-9108
Document date2026-11-01
AuthorHarriet Pell, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Primary care visit for a right breast lump and a year of breast ache. Concerns: A heavy, dull ache in the right breast for about a year and a firm lump she noticed two months ago; Dreads an operation; wants every step explained in advance and to be warned before anything is done. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth every 6 hours for pain after surgery, no more than 3000 mg a dayTwo tablets every 6 hoursOral route2026-09-30 to 2026-10-14completedS
Ibuprofen 400 mg oral tablet, one tablet by mouth every 8 hours with food for five days after surgeryOne tablet every 8 hours with foodOral route2026-09-30 to 2026-10-05completedS
Anastrozole 1 mg oral tablet, one tablet by mouth once daily, planned for five yearsOne tablet once dailyOral route2026-10-19activeS
Cholecalciferol (vitamin D3) 1000 units oral tablet, one tablet by mouth once dailyOne tablet once dailyOral route2026-10-19activeS

Procedures

ProcedureDatesStatusEvidence
Diagnostic bilateral mammography: 2.4 cm irregular spiculated mass at 10 o'clock in the upper outer right breast; heterogeneously dense breasts; left breast normal; BI-RADS 52026-08-12 to 2026-08-12completedS
Right breast and axillary ultrasound: 2.5 cm irregular hypoechoic mass at 10 o'clock, 6 cm from the nipple; normal axillary lymph nodes2026-08-12 to 2026-08-12completedS
Ultrasound-guided core needle biopsy of the right breast mass with clip placement: invasive ductal carcinoma, grade 2; ER 95 percent, PR 70 percent, HER2 1+ (negative), Ki-67 15 percent2026-08-14 to 2026-08-14completedS
Bilateral breast MRI with contrast for extent of disease: index mass 2.6 cm; a second 0.8 cm enhancing mass at 7 o'clock in the right breast, 5 cm from the index mass; left breast normal; no enlarged nodes2026-08-28 to 2026-08-28completedS
MRI-guided core needle biopsy of the second right breast lesion: invasive ductal carcinoma, grade 2, ER positive, HER2 negative (multicentric disease)2026-09-03 to 2026-09-03completedS
Right total mastectomy without reconstruction, her choice, under general anesthesia; overnight stay. Pathology: multicentric invasive ductal carcinoma, 2.6 cm and 0.8 cm, grade 2, margins clear, no lymphovascular invasion; pT2(m) pN0(sn), anatomic stage IIA. Recurrence score (21-gene assay) 132026-09-30 to 2026-09-30completedS
Right axillary sentinel lymph node biopsy at mastectomy (radioisotope and blue dye): 0 of 3 nodes involved2026-09-30 to 2026-09-30completedS
Ultrasound-guided pectoral nerve block (PECS II) with ropivacaine before incision, for pain control after mastectomy2026-09-30 to 2026-09-30completedS
Baseline bone density scan (DXA) before anastrozole: lumbar spine T-score -1.4, femoral neck T-score -1.7 (low bone mass)2026-10-19 to 2026-10-19completedS
Aspiration of a right chest wall seroma by the breast surgery team: 140 mL of clear straw-colored fluid; no signs of infection2026-10-08 to 2026-10-08completedS

Immunizations

DateVaccineStatusEvidence
2025-10-20Influenza vaccine, 2025-2026 seasoncompletedS
2020-04-15Tdap vaccinecompletedS
2026-10-29Influenza vaccine, 2026-2027 seasoncompletedS
2026-10-29Pneumococcal conjugate vaccine PCV20completedS
2026-10-29Recombinant zoster vaccine, dose 1 of 2completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
December 1794One pregnancy; her only child born when she was 42D (CLM-0003)
About August 1810A small, heavy pain in the breast from about August 1810, increasing week by week, treated for months without success, with a hardening of the affected spot and her right arm kept from use; the breast was not discoloredD (CLM-0005)

Family History

RelativeConditionAge at deathEvidence
motherDied in 1762, when Burney was about ten; cause not recorded in the cited sourceD (CLM-0002)

Health Concerns

ConcernStatusEvidence
A heavy, dull ache in the right breast for about a year and a firm lump she noticed two months agoactiveS
Dreads an operation; wants every step explained in advance and to be warned before anything is doneactiveS

Assessment

Most recent measures: Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 2026-10-29; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 5 on 2026-08-24; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 7 on 2026-08-24; Cholesterol [Mass/volume] in Serum or Plasma 214 on 2026-10-19; Cholesterol in HDL [Mass/volume] in Serum or Plasma 58 on 2026-10-19; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 132 on 2026-10-19; Triglyceride [Mass/volume] in Serum or Plasma 120 on 2026-10-19; 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 24 on 2026-10-19; DXA Lumbar spine [T-score] Bone density -1.4 on 2026-10-19; DXA Femur [T-score] Bone density -1.7 on 2026-10-19; Total score [AUDIT-C] 2 on 2026-10-29 [S]

Strengths and supports: Supports: her husband and son and a wide circle of friends who visit often [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Invasive ductal carcinoma of the right breast, upper outer quadrant at 10 o'clock, presenting as a firm lump after about a year of breast ache; core biopsy: grade 2, estrogen and progesterone receptor positive, HER2 negative; clinical stage T2 N0 (cT2 cN0 M0); synthetic modern diagnosis linked to the documented 1811 breast disease and mastectomy, whose cancer diagnosis is debatedactiveconfirmed C50.411S — Synthetic diagnosis confirmed by biopsy and surgical pathology in the modern episode; whether her historical disease was cancer remains a retrospective interpretation (R).
Estrogen receptor positive status of the breast cancer (ER 95 percent, PR 70 percent)activeconfirmed Z17.0S — Synthetic receptor result; no tissue from her lifetime was examined.
Absence of the right breast after total mastectomy without reconstruction, her choiceactiveconfirmed Z90.11S — Synthetic coding of the modern mastectomy, which echoes the documented operation.
Long-term use of anastrozole as adjuvant endocrine therapyactiveconfirmed Z79.811S — Synthetic treatment status.
Low bone mass (osteopenia) on baseline DXA before anastrozole: lumbar spine T-score -1.4, femoral neck -1.7; 10-year major osteoporotic fracture risk about 8 percent (FRAX); vitamin D insufficiencyactiveconfirmed M85.80S — Synthetic finding on the baseline DXA the protocol requires for an aromatase inhibitor.
Seroma under the right mastectomy flap after drain removal, without infection; aspirated once by the breast surgery team; resolvedresolvedconfirmed L76.34S — Synthetic common complication of the synthetic mastectomy; it does not echo a documented illness.
Firm lump in the upper outer quadrant of the right breast after about a year of heavy breast ache; clinically suspicious, imaging and biopsy bookedresolvedconfirmed N63.11S — Synthetic presenting concern at the index visit, superseded by the biopsy diagnosis; the year of breast ache echoes her documented account (D).

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-08-10Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
2026-08-24Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
2026-08-24Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]7{score}S
2026-10-19Cholesterol [Mass/volume] in Serum or Plasma214mg/dL<=199 mg/dLHighS
2026-10-19Cholesterol in HDL [Mass/volume] in Serum or Plasma58mg/dL>=50 mg/dLNormalS
2026-10-19Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation132mg/dL<=99 mg/dLHighS
2026-10-19Triglyceride [Mass/volume] in Serum or Plasma120mg/dL<=149 mg/dLNormalS
2026-10-1925-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma24ng/mL30-100 ng/mLLowS
2026-10-19Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
2026-10-19DXA Lumbar spine [T-score] Bone density-1.4{T-score}>=-1LowS
2026-10-19DXA Femur [T-score] Bone density-1.7{T-score}>=-1LowS
2026-10-29Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-10-29Total score [AUDIT-C]2{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-08-10Body height160cmS
2026-08-10Body weight62kgS
2026-08-10Body mass index (BMI) [Ratio]24.2kg/m2S
2026-08-10Systolic blood pressure128mm[Hg]S
2026-08-10Diastolic blood pressure80mm[Hg]S
2026-08-10Heart rate82/minS
2026-08-10Respiratory rate14/minS
2026-08-10Body temperature36.7CelS
2026-08-10Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-08-24Body height160cmS
2026-08-24Body weight61.6kgS
2026-08-24Body mass index (BMI) [Ratio]24.1kg/m2S
2026-08-24Systolic blood pressure132mm[Hg]S
2026-08-24Diastolic blood pressure82mm[Hg]S
2026-08-24Heart rate86/minS
2026-08-24Respiratory rate14/minS
2026-08-24Body temperature36.6CelS
2026-08-24Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-10-19Body height160cmS
2026-10-19Body weight60.9kgS
2026-10-19Body mass index (BMI) [Ratio]23.8kg/m2S
2026-10-19Systolic blood pressure122mm[Hg]S
2026-10-19Diastolic blood pressure76mm[Hg]S
2026-10-19Heart rate74/minS
2026-10-19Respiratory rate14/minS
2026-10-19Body temperature36.6CelS
2026-10-19Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-10-08Body height160cmS
2026-10-08Body weight60.8kgS
2026-10-08Body mass index (BMI) [Ratio]23.7kg/m2S
2026-10-08Systolic blood pressure124mm[Hg]S
2026-10-08Diastolic blood pressure78mm[Hg]S
2026-10-08Heart rate80/minS
2026-10-08Respiratory rate14/minS
2026-10-08Body temperature36.9CelS
2026-10-08Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-10-29Body height160cmS
2026-10-29Body weight61.2kgS
2026-10-29Body mass index (BMI) [Ratio]23.9kg/m2S
2026-10-29Systolic blood pressure120mm[Hg]S
2026-10-29Diastolic blood pressure76mm[Hg]S
2026-10-29Heart rate72/minS
2026-10-29Respiratory rate14/minS
2026-10-29Body temperature36.6CelS
2026-10-29Oxygen saturation in Arterial blood by Pulse oximetry99%S

Encounters

DatePurposeStatusProvenance
2026-08-10Primary care visit for a right breast lump and a year of breast achefinishedS
2026-08-24Review of mammogram, ultrasound, and core biopsy showing breast cancer; breast surgery consultationfinishedS
2026-10-19Review three weeks after right mastectomy; start of endocrine therapy and survivorship carefinishedS
2026-10-08Same-day sick visit for swelling under the mastectomy scarfinishedS
2026-10-29Adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Diagnostic mammography and ultrasound, then image-guided core biopsy with ER, PR, and HER2 testing, for a palpable breast mass in a woman of 59completedGL-NCCN-BREAST-2025, GL-CMID-2026S
Breast surgery consultation to discuss surgical options, imaging of the extent of disease, axillary staging, and anesthesia and pain controlcompletedGL-NCCN-BREAST-2025S
Germline genetic testing before surgery, as recommended for breast cancer diagnosed at 65 or youngercompletedGL-ASCO-SSO-GERM-2024S
Right total mastectomy with sentinel lymph node biopsy under general anesthesia with a pectoral nerve block and an opioid-sparing recovery pathwaycompletedGL-NCCN-BREAST-2025S
Anastrozole 1 mg daily for five years, with a baseline DXA repeated every two years, vitamin D and calcium, lipid monitoring, and questions about joint pain, hot flashes, and vaginal symptoms at every visitcompletedGL-ASCO-ENDO-2019, GL-CMID-2026S
Survivorship care: history and examination every 3 to 6 months for 3 years and a yearly mammogram of the left breast, with no routine blood tests or body imaging; lymphedema counseling and shoulder exercises; distress screening; a written survivorship care plancompletedGL-CMID-2026, GL-ACS-ASCO-SURV-2016, GL-ASCO-FU-2013S

Goals

GoalTargetStatusOutcomeProvenance
Complete diagnosis, staging, and surgery within eight weeks of presentation2026-10-19completedCore biopsy in four days, MRI and a second biopsy within four weeks, mastectomy at seven weeksS
Surgery under anesthesia with pain controlled without opioids after discharge2026-10-19completedPain 2 out of 10 by the third day; no opioid after leaving hospital; acetaminophen stopped at two weeksS
Start adjuvant endocrine therapy with a bone-health plan2026-10-19completedAnastrozole started; baseline DXA shows low bone mass; vitamin D startedS
Regain full right shoulder movement and keep lymphedema risk low2026-10-29activeShoulder flexion 165 degrees at four weeks, nearly full, with physical therapy under way; arm circumferences equalS

Functional Status

Mental Status